Waldenström's macroglobulinemia surgery: Difference between revisions
No edit summary |
Sara Mohsin (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Surgery is not the first-line treatment option for patients with | [[Surgery]] is not the [[first-line treatment]] option for [[patients]] with [[lymphoplasmacytic lymphoma]]. [[Stem cell transplant]] is usually reserved for [[patients]] with either [[relapse]] or [[refractory]] [[lymphoplasmacytic lymphoma]]. | ||
==Surgery== | ==Surgery== | ||
*[[Stem cell transplant]] is usually reserved for patients when either lymphoma comes back (recurs/relapses) after treatment or doesn’t respond to other treatments (called refractory disease).<ref name="sure">Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015) http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015</ref> | *[[Stem cell transplant]] is usually reserved for [[patients]] when either [[lymphoma]] comes [[back]] ([[Recurrence plot|recurs]]/[[Relapse|relapses]]) after [[Treatments|treatment]] or doesn’t [[Response element|respond]] to other [[treatments]] (called [[refractory]] [[disease]]).<ref name="sure">Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015) http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015</ref> | ||
*Many people with [[lymphoplasmacytic lymphoma]] are older or may not be in good health, so a stem cell transplant may not be a good treatment option for them. | *Many [[People's Solidarity|people]] with [[lymphoplasmacytic lymphoma]] are [[Old age|older]] or may not be in good [[health]], so a [[stem cell transplant]] may not be a good [[Treatments|treatment]] option for them. | ||
*In very [[rare]] [[Case-based reasoning|cases]], laporotomy or laproscopy might be required. | |||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Blood]] | [[Category:Blood]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Revision as of 01:18, 15 August 2019
|
Waldenström's macroglobulinemia Microchapters |
|
Differentiating Waldenström's macroglobulinemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Waldenström's macroglobulinemia surgery On the Web |
|
American Roentgen Ray Society Images of Waldenström's macroglobulinemia surgery |
|
Directions to Hospitals Treating Waldenström's macroglobulinemia |
|
Risk calculators and risk factors for Waldenström's macroglobulinemia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2], Mirdula Sharma, MBBS [3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]
Overview
Surgery is not the first-line treatment option for patients with lymphoplasmacytic lymphoma. Stem cell transplant is usually reserved for patients with either relapse or refractory lymphoplasmacytic lymphoma.
Surgery
- Stem cell transplant is usually reserved for patients when either lymphoma comes back (recurs/relapses) after treatment or doesn’t respond to other treatments (called refractory disease).[1]
- Many people with lymphoplasmacytic lymphoma are older or may not be in good health, so a stem cell transplant may not be a good treatment option for them.
- In very rare cases, laporotomy or laproscopy might be required.
References
- ↑ Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015) http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015